Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy across a Large Health System during a Global Pandemic

15Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Emergency authorized coronavirus disease 2019 (COVID-19)-neutralizing monoclonal antibodies can aid outpatients with mild to moderate COVID-19 infection. Many report barriers to adequate distribution and uptake. We present our model for distribution in a large health system as well as early lessons learned.

Cite

CITATION STYLE

APA

Bariola, J. R., McCreary, E. K., Khadem, T., Snyder, G. M., Wadas, R. J., Nace, D. A., … Schmidhofer, M. (2021). Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy across a Large Health System during a Global Pandemic. Open Forum Infectious Diseases, 8(7). https://doi.org/10.1093/ofid/ofab151

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free